Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FAWKB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,230
Award facts
- Contract value 100% obligated
- $11,230.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,230.19 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Vraylar 1.5 mg capsules (30-count packages). This firm fixed-price delivery order, which is scheduled for completion by September 11, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. The delivery will be performed at a facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, allowing DMS Pharmaceutical Group to compete openly in the federal procurement marketplace.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor and subcontractors are not identified in this award documentation. The company holds a significant single-award IDC valued at $499,999,999 through November 2026, which enables the DLA to issue firm fixed-price delivery orders across a comprehensive portfolio of pharmaceutical products to support military health facilities. Through this vehicle, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, providing prescription medications, over-the-counter products, biologics, and medical consumables directly to Department of Defense healthcare sites worldwide.
Quick answers
Who was awarded contract SPE2DB25FAWKB?
SPE2DB25FAWKB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FAWKB worth?
The government has obligated $11,230 on SPE2DB25FAWKB.
Is contract SPE2DB25FAWKB an order under another contract?
Yes. SPE2DB25FAWKB is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWKB competed?
The extent of competition for SPE2DB25FAWKB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award